insights_auto
Why is EDIT down 4.09%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
$1.64
arrow_downward
-4.09%(-0.070) 1D
$1.66
arrow_upward
+1.22% (+0.020)bedtimeAfter hours
Closed: Nov 20, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$1.69
High
$1.78
Low
$1.63
Mkt. cap
253.12M
Avg. vol.
2.24M
Volume
2.68M
52-wk high
$3.94
52-wk low
$1.63
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
Open
$1.69
High
$1.78
Low
$1.63
Mkt. cap
253.12M
Avg. vol.
2.24M
Volume
2.68M
52-wk high
$3.94
52-wk low
$1.63
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
News stories
From web sources and news partners
Investing.com
·
41 minutes ago
How exposed is the S&P 500 to an AI trade bust?
BeInCrypto
·
9 hours ago
China, Korea and Taiwan Rush Stock Rescues Before Monday: Can They Help the S&P 500?
Bloomberg.com
·
1 hour ago
S&P 500 at 5,600? Crushing China’s AI Ambitions Has a Price
cwibc.co.id
·
18 minutes ago
S&P 500 Faces Thanksgiving Week After Sharp Market Selloff
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com